The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month in some cases, officials said.
The Supreme Court agreed to freeze a lower court order that stopped the State Department from enforcing a new passport policy put into place by President Trump earlier this year.
